178 related articles for article (PubMed ID: 37077580)
1. Impact of C-reactive protein levels on lipoprotein(a)-associated aortic stenosis incidence and progression.
Girard A; Gaillard E; Puri R; Capoulade R; Chan KL; Paulin A; Manikpurage HD; Dumesnil J; Tam JW; Teo KK; Couture C; Wareham NJ; Clavel MA; Stroes ESG; Mathieu P; Thériault S; Tsimikas S; Pibarot P; Boekholdt SM; Arsenault BJ
Eur Heart J Open; 2023 Mar; 3(2):oead032. PubMed ID: 37077580
[TBL] [Abstract][Full Text] [Related]
2. Genetic Variation in LPA, Calcific Aortic Valve Stenosis in Patients Undergoing Cardiac Surgery, and Familial Risk of Aortic Valve Microcalcification.
Perrot N; Thériault S; Dina C; Chen HY; Boekholdt SM; Rigade S; Després AA; Poulin A; Capoulade R; Le Tourneau T; Messika-Zeitoun D; Trottier M; Tessier M; Guimond J; Nadeau M; Engert JC; Khaw KT; Wareham NJ; Dweck MR; Mathieu P; Pibarot P; Schott JJ; Thanassoulis G; Clavel MA; Bossé Y; Arsenault BJ
JAMA Cardiol; 2019 Jul; 4(7):620-627. PubMed ID: 31141105
[TBL] [Abstract][Full Text] [Related]
3. Sex-Specific Associations of Genetically Predicted Circulating Lp(a) (Lipoprotein(a)) and Hepatic
Guertin J; Kaiser Y; Manikpurage H; Perrot N; Bourgeois R; Couture C; Wareham NJ; Bossé Y; Pibarot P; Stroes ESG; Mathieu P; Clavel MA; Thériault S; Boekholdt SM; Arsenault BJ
Circ Genom Precis Med; 2021 Aug; 14(4):e003271. PubMed ID: 34279996
[TBL] [Abstract][Full Text] [Related]
4. Autotaxin interacts with lipoprotein(a) and oxidized phospholipids in predicting the risk of calcific aortic valve stenosis in patients with coronary artery disease.
Nsaibia MJ; Mahmut A; Boulanger MC; Arsenault BJ; Bouchareb R; Simard S; Witztum JL; Clavel MA; Pibarot P; Bossé Y; Tsimikas S; Mathieu P
J Intern Med; 2016 Nov; 280(5):509-517. PubMed ID: 27237700
[TBL] [Abstract][Full Text] [Related]
5. Lipoprotein-associated phospholipase A2 activity, genetics and calcific aortic valve stenosis in humans.
Perrot N; Thériault S; Rigade S; Chen HY; Dina C; Martinsson A; Boekholdt SM; Capoulade R; Le Tourneau T; Messika-Zeitoun D; Engert JC; Wareham NJ; Clavel MA; Pibarot P; Smith JG; Schott JJ; Mathieu P; Bossé Y; Thanassoulis G; Arsenault BJ
Heart; 2020 Sep; 106(18):1407-1412. PubMed ID: 32636298
[TBL] [Abstract][Full Text] [Related]
6. Autoantibodies and immune complexes to oxidation-specific epitopes and progression of aortic stenosis: Results from the ASTRONOMER trial.
Capoulade R; Chan KL; Mathieu P; Bossé Y; Dumesnil JG; Tam JW; Teo KK; Yang X; Witztum JL; Arsenault BJ; Després JP; Pibarot P; Tsimikas S
Atherosclerosis; 2017 May; 260():1-7. PubMed ID: 28319871
[TBL] [Abstract][Full Text] [Related]
7. Association of Mild to Moderate Aortic Valve Stenosis Progression With Higher Lipoprotein(a) and Oxidized Phospholipid Levels: Secondary Analysis of a Randomized Clinical Trial.
Capoulade R; Yeang C; Chan KL; Pibarot P; Tsimikas S
JAMA Cardiol; 2018 Dec; 3(12):1212-1217. PubMed ID: 30476957
[TBL] [Abstract][Full Text] [Related]
8. Plasma Lipoprotein(a) measured in routine clinical care and the association with incident calcified aortic valve stenosis during a 14-year observational period.
Wodaje T; Littmann K; Häbel H; Bottai M; Bäck M; Parini P; Brinck J
Atherosclerosis; 2022 May; 349():175-182. PubMed ID: 35277251
[TBL] [Abstract][Full Text] [Related]
9. Lipoprotein(a) and Its Autoantibodies in Association with Calcific Aortic Valve Stenosis.
Burdeynaya AL; Afanasieva OI; Ezhov MV; Klesareva EA; Saidova MA; Pokrovsky SN
Diseases; 2023 Mar; 11(1):. PubMed ID: 36975592
[TBL] [Abstract][Full Text] [Related]
10. Lipoprotein(a), Oxidized Phospholipids, and Aortic Valve Microcalcification Assessed by 18F-Sodium Fluoride Positron Emission Tomography and Computed Tomography.
Després AA; Perrot N; Poulin A; Tastet L; Shen M; Chen HY; Bourgeois R; Trottier M; Tessier M; Guimond J; Nadeau M; Engert JC; Thériault S; Bossé Y; Witztum JL; Couture P; Mathieu P; Dweck MR; Tsimikas S; Thanassoulis G; Pibarot P; Clavel MA; Arsenault BJ
CJC Open; 2019 May; 1(3):131-140. PubMed ID: 32159096
[TBL] [Abstract][Full Text] [Related]
11. Interaction of Autotaxin With Lipoprotein(a) in Patients With Calcific Aortic Valve Stenosis.
Bourgeois R; Devillers R; Perrot N; Després AA; Boulanger MC; Mitchell PL; Guertin J; Couture P; Boffa MB; Scipione CA; Pibarot P; Koschinsky ML; Mathieu P; Arsenault BJ
JACC Basic Transl Sci; 2020 Sep; 5(9):888-897. PubMed ID: 33015412
[TBL] [Abstract][Full Text] [Related]
12. Lipoprotein Proteomics and Aortic Valve Transcriptomics Identify Biological Pathways Linking Lipoprotein(a) Levels to Aortic Stenosis.
Bourgeois R; Bourgault J; Despres AA; Perrot N; Guertin J; Girard A; Mitchell PL; Gotti C; Bourassa S; Scipione CA; Gaudreault N; Boffa MB; Koschinsky ML; Pibarot P; Droit A; Thériault S; Mathieu P; Bossé Y; Arsenault BJ
Metabolites; 2021 Jul; 11(7):. PubMed ID: 34357353
[TBL] [Abstract][Full Text] [Related]
13. apoB/apoA-I Ratio and Lp(a) Associations With Aortic Valve Stenosis Incidence: Insights From the EPIC-Norfolk Prospective Population Study.
Zheng KH; Arsenault BJ; Kaiser Y; Khaw KT; Wareham NJ; Stroes ESG; Boekholdt SM
J Am Heart Assoc; 2019 Aug; 8(16):e013020. PubMed ID: 31407609
[TBL] [Abstract][Full Text] [Related]
14. The Prevalence of Lipoprotein(a) Measurement and Degree of Elevation Among 2710 Patients With Calcific Aortic Valve Stenosis in an Academic Echocardiography Laboratory Setting.
Wilkinson MJ; Ma GS; Yeang C; Ang L; Strachan M; DeMaria AN; Tsimikas S; Cotter B
Angiology; 2017 Oct; 68(9):795-798. PubMed ID: 28068801
[TBL] [Abstract][Full Text] [Related]
15. Association of serum lipoprotein(a) level with the severity and prognosis of calcific aortic valve stenosis: a Chinese cohort study.
Liu SL; Rozi R; Shi HW; Gao Y; Guo YL; Tang YD; Li JJ; Wu NQ
J Geriatr Cardiol; 2020 Mar; 17(3):133-140. PubMed ID: 32280329
[TBL] [Abstract][Full Text] [Related]
16. Lipoprotein(a) in Patients Undergoing Transcatheter Aortic Valve Replacement.
Ma GS; Wilkinson MJ; Reeves RR; Yeang C; DeMaria AN; Cotter B; Patel M; Mahmud E; Tsimikas S
Angiology; 2019 Apr; 70(4):332-336. PubMed ID: 30700108
[TBL] [Abstract][Full Text] [Related]
17. The current landscape of lipoprotein(a) in calcific aortic valvular disease.
Hsieh G; Rizk T; Berman AN; Biery DW; Blankstein R
Curr Opin Cardiol; 2021 Sep; 36(5):542-548. PubMed ID: 34397461
[TBL] [Abstract][Full Text] [Related]
18. Genetic and In Vitro Inhibition of
Perrot N; Valerio V; Moschetta D; Boekholdt SM; Dina C; Chen HY; Abner E; Martinsson A; Manikpurage HD; Rigade S; Capoulade R; Mass E; Clavel MA; Le Tourneau T; Messika-Zeitoun D; Wareham NJ; Engert JC; Polvani G; Pibarot P; Esko T; Smith JG; Mathieu P; Thanassoulis G; Schott JJ; Bossé Y; Camera M; Thériault S; Poggio P; Arsenault BJ
JACC Basic Transl Sci; 2020 Jul; 5(7):649-661. PubMed ID: 32760854
[TBL] [Abstract][Full Text] [Related]
19. Life's simple 7 and calcific aortic valve stenosis incidence in apparently healthy men and women.
Perrot N; Boekholdt SM; Mathieu P; Wareham NJ; Khaw KT; Arsenault BJ
Int J Cardiol; 2018 Oct; 269():226-228. PubMed ID: 30054144
[TBL] [Abstract][Full Text] [Related]
20. Lipoprotein(a) and calcific aortic valve stenosis: A systematic review.
Guddeti RR; Patil S; Ahmed A; Sharma A; Aboeata A; Lavie CJ; Alla VM
Prog Cardiovasc Dis; 2020; 63(4):496-502. PubMed ID: 32526213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
